Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Prehab and Creatine/Whey Supplements in Cirrhosis-Related Frailty

Official title: Physical Prehabilitation With and Without Creatine/Whey Protein Supplementation Effects on Frailty In Patients With Cirrhosis

Run by University of California, San Francisco · NCT07029243 · Data updated 2026-11-12

This study tests whether a digital prehabilitation app plus creatine and whey protein can help maintain muscle health in people with cirrhosis and frailty.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedApril 15, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJuly 15, 2026
Trial IDNCT07029243 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a confirmed cirrhosis diagnosis who are frail or have reduced muscle health and can use a digital device for at least 3 months.

Probably not a fit

Patients without frailty or with contraindications to dairy-derived supplements or who cannot comply with digital app use may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study combines a digital prehabilitation program (HEAL-ME) with creatine and whey protein supplementation to see if it preserves muscle health in patients with cirrhosis. Participants must have access to a digital device, be able to consent, and stay in the study for at least 3 months. The intervention arms include HEAL-ME, creatine, whey protein, and a placebo, with eligibility excluding milk protein allergy and certain safety concerns. The study is led by UCSF and conducted at UCSF in San Francisco. No collaborating sites are listed.

Why it matters

Potential benefit: If successful, participants may experience preserved or improved muscle health and functional status during cirrhosis management.

How similar studies have gone: Prior research in nutrition and prehabilitation suggests potential benefits for muscle health, though this specific combination with a digital app is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed diagnosis of cirrhosis by ICD-10 code, liver biopsy, abdominal imaging, or transient elastography
* Access to digital device and internet at home
* Ability to provide written informed consent before any study-related activities
* Ability to remain in study for at least 3 months

Exclusion Criteria:

* Allergy to milk protein
* On hemodialysis
* No English language proficiency
* Presence of condition or abnormality that in opinion of the Investigator will compromise safety of the patient or quality of the data
* Concomitant severe underlying systemic illness that in the opinion of the Investigator would interfere with completion of study
* Pregnant, breastfeeding, or intention of becoming pregnant during study time frame

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Jennifer Lai, MD, MBA — University of California, San Francisco
  • Study coordinator: Melinda Wang, MD, MHS
  • Email: melinda.wang3@ucsf.edu
  • Phone: 415-476-2777

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.